Chemoinformaics analysis of 3beta,16alpha-dihydroxy-olean-13(18)-en-28-oic acid
| Molecular Weight | 472.71 | nRot | 1 |
| Heavy Atom Molecular Weight | 424.326 | nRig | 27 |
| Exact Molecular Weight | 472.355 | nRing | 5 |
| Solubility: LogS | -3.801 | nHRing | 0 |
| Solubility: LogP | 5.26 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 85.3141 |
| nHD | 3 | BPOL | 49.0219 |
| QED | 0.397 |
| Synth | 4.795 |
| Natural Product Likeliness | 3.31 |
| NR-PPAR-gamma | 0.966 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0 |
| HIA | 0.026 |
| CACO-2 | -5.292 |
| MDCK | 0.0000167 |
| BBB | 0.985 |
| PPB | 0.938714 |
| VDSS | 0.843 |
| FU | 0.0492095 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.297 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.931 |
| CYP2c9-inh | 0.112 |
| CYP2c9-sub | 0.911 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.394 |
| CYP3a4-inh | 0.124 |
| CYP3a4-sub | 0.203 |
| CL | 6.23 |
| T12 | 0.022 |
| hERG | 0.002 |
| Ames | 0.022 |
| ROA | 0.119 |
| SkinSen | 0.015 |
| Carcinogencity | 0.052 |
| EI | 0.118 |
| Respiratory | 0.974 |
| NR-Aromatase | 0.821 |
| Antiviral | No |
| Prediction | 0.690757 |